Natus Acquires Holberg EEG, Expanding Innovation in Neurodiagnostic AI Solutions

MIDDLETON, Wis., Sept. 30, 2025 /PRNewswire/ -- Natus Medical Incorporated, the largest global pure-play neurodiagnostics company, today announced it has acquired the remaining minority shares in Holberg EEG, the pioneering developer of the world's first artificial intelligence (AI) model capable of automatic and comprehensive clinical EEG interpretation with accuracy on par with leading medical experts. With this transaction, Natus now owns 100% of Holberg EEG.

The acquisition combines the groundbreaking technology of Holberg EEG with the industry-leading neurodiagnostics portfolio of Natus, creating new opportunities to advance brain health through smarter, more accessible solutions.

"Bringing Holberg EEG into the Natus family is an exciting and strategic milestone for our company and the field of neurodiagnostics," said Chris Landon, CEO of Natus. "This acquisition allows us to accelerate the adoption of cutting-edge AI technology that empowers healthcare providers and technologists with faster, more accurate EEG interpretation – improving patient outcomes worldwide. We are proud to unite our deep heritage in neuro care with Holberg's groundbreaking innovation, creating a powerful force for advancing brain health for decades."

The Holberg EEG AI model delivers unprecedented efficiency and diagnostic confidence for clinicians interpreting complex EEG data, addressing a significant gap in neurological care. By integrating the Holberg EEG AI with the trusted EEG systems and neurodiagnostic solutions of Natus, healthcare providers and clinicians worldwide will benefit from streamlined workflows, enhanced accuracy, and improved patient outcomes.

Founded in 2009, Holberg EEG brings deep expertise in AI-assisted EEG interpretation. Its flagship innovation, autoSCORE, introduced to the U.S. market in August 2024, was designed to alleviate the demands on clinical resources through a deep-learning model trained on more than 30,000 expertly labeled EEG recordings. Offered exclusively with Natus NeuroWorks® software, autoSCORE is FDA 510(k) cleared for routine EEG, long-term monitoring (LTM), and ambulatory EEG studies, and has also received the CE mark for European and other applicable countries.

Together, the combined 85+ years of neurodiagnostic leadership of Natus and Holberg EEG will continue to pursue AI-powered innovation to improve the lives of patients around the world.

About Natus

Natus is trusted by healthcare providers around the globe as the solution source to screen, diagnose, and treat disorders affecting the brain and neural pathways. The best-in-class Natus solutions, including service, field support, and education, enable clinicians to advance their standard of care, improving patient outcomes and quality of life. For more information, visit natus.com/neuro.

About Holberg EEG

Holberg EEG is a spin-off company from Haukeland University Hospital in Bergen, Norway, focused on uniting structured EEG data with artificial intelligence to improve patient care. Its flagship innovation, autoSCORE, is transforming EEG interpretation worldwide.

CONTACT INFORMATION:  
Lisa Schuler
Sr. Director, Corporate Communications & PR
Phone: +1 612 528-1332
Email: [email protected]

SOURCE Natus Medical Incorporated